Newsletter | March 14, 2026

03.14.26 -- Life Science Leader Best Of February

FEBRUARY'S BEST FEATURED EDITORIAL

Why Human Leadership Matters More Than Ever In The AI Era

In the AI era, thriving life sciences organizations will differentiate themselves based on their ability to combine AI's power with distinctly human capabilities, writes Christine Ann Miller.

FEBRUARY'S BEST INDUSTRY INSIGHTS

Transforming Lentiviral Vector Manufacturing For In Vivo, Ex Vivo CAR‑T

Discover how scalable, cost-effective, and high-quality lentiviral vector manufacturing can accelerate both ex vivo and emerging in vivo CAR-T therapies.

Recent Updates To The Declaration Of Helsinki Affecting Clinical Trials

The World Medical Association has released a rare major update to the Declaration of Helsinki, the core ethical guide for medical research involving human participants.

Quality Roundtable: Raw Materials In Biologics Scale‑Up

Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.